Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (5)

1

HDAC inhibitors suppress protein poly(ADP-ribosyl)ation and DNA repair protein levels and phosphorylation status in hematologic cancer cells : implications for their use in combination with PARP inhibitors and chemotherapeutic drugs

enthalten in: Oncotarget | 2022

von Valdez, B. | Nieto, Y. | Yuan, B. | +2

2

Targeting Krebs-cycle-deficient renal cell carcinoma with Poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy

enthalten in: Oncotarget | 2022

von Ueno, D. | Vasquez, J. | Sule, A. | +15

3

Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models

enthalten in: Oncotarget | 2022

von Stolzenburg, L. | Ainsworth, B. | Riley-Gillis, B. | +5

4

PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression

enthalten in: Oncotarget | 2015

von Mariano, G. | Ricciardi, M. | Trisciuoglio, D. | +9

5

Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity

enthalten in: Oncotarget | 2015

von Frankum, J. | Moudry, P. | Brough, R. | +4

1
[1]